Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 2

Results: 11

Imeglimin: Current Development and Future Potential in Type 2 Diabetes.

Published in:

Drugs, 2021, v. 81, n. 2, p. 185, doi. 10.1007/s40265-020-01434-5

By:

Konkwo, Chigoziri;
Perry, Rachel J.

Publication type:

Article

Correction to: Filgotinib: First Approval.

Published in:

Drugs, 2021, v. 81, n. 2, p. 297, doi. 10.1007/s40265-021-01468-3

By:

Dhillon, Sohita;
Keam, Susan J.

Publication type:

Article

Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Published in:

Drugs, 2021, v. 81, n. 2, p. 333, doi. 10.1007/s40265-020-01460-3

By:

Hanzel, Jurij;
Ma, Christopher;
Casteele, Niels Vande;
Khanna, Reena;
Jairath, Vipul;
Feagan, Brian G.

Publication type:

Article

Naxitamab: First Approval.

Published in:

Drugs, 2021, v. 81, n. 2, p. 291, doi. 10.1007/s40265-021-01467-4

By:

Markham, Anthony

Publication type:

Article

Lonafarnib: First Approval.

Published in:

Drugs, 2021, v. 81, n. 2, p. 283, doi. 10.1007/s40265-020-01464-z

By:

Dhillon, Sohita

Publication type:

Article

Lumasiran: First Approval.

Published in:

Drugs, 2021, v. 81, n. 2, p. 277, doi. 10.1007/s40265-020-01463-0

By:

Scott, Lesley J.;
Keam, Susan J.

Publication type:

Article

Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer.

Published in:

Drugs, 2021, v. 81, n. 2, p. 191, doi. 10.1007/s40265-020-01456-z

By:

Rathi, Nityam;
McFarland, Taylor Ryan;
Nussenzveig, Roberto;
Agarwal, Neeraj;
Swami, Umang

Publication type:

Article

Brigatinib: A Review in ALK-Inhibitor Naïve Advanced ALK-Positive NSCLC.

Published in:

Drugs, 2021, v. 81, n. 2, p. 267, doi. 10.1007/s40265-020-01449-y

By:

Hoy, Sheridan M.

Publication type:

Article

Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.

Published in:

Drugs, 2021, v. 81, n. 2, p. 233, doi. 10.1007/s40265-020-01443-4

By:

Zhanel, George G.;
Deng, Christina;
Zelenitsky, Sheryl;
Lawrence, Courtney K.;
Adam, Heather J.;
Golden, Alyssa;
Berry, Liam;
Schweizer, Frank;
Zhanel, Michael A.;
Irfan, Neal;
Bay, Denice;
Lagacé-Wiens, Philippe;
Walkty, Andrew;
Mandell, Lionel;
Lynch III, Joseph P.;
Karlowsky, James A.

Publication type:

Article

Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

Published in:

Drugs, 2021, v. 81, n. 2, p. 257, doi. 10.1007/s40265-020-01441-6

By:

Mok, Tony S.;
Cheng, Ying;
Zhou, Xiangdong;
Lee, Ki Hyeong;
Nakagawa, Kazuhiko;
Niho, Seiji;
Chawla, Alka;
Rosell, Rafael;
Corral, Jesus;
Migliorino, Maria Rita;
Pluzanski, Adam;
Noonan, Kay;
Tang, Yiyun;
Pastel, Malaika;
Wilner, Keith D.;
Wu, Yi-Long

Publication type:

Article

Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects.

Published in:

Drugs, 2021, v. 81, n. 2, p. 207, doi. 10.1007/s40265-020-01431-8

By:

Chun, Jerold;
Giovannoni, Gavin;
Hunter, Samuel F.

Publication type:

Article